Author

Juan Lloberas

Observed name: J Lloberas

Observed institution: Hospital Italiano de Montevideo

OpenAlex ID: A5009604635

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

2016 · Carlos Haiek, Carlos Fernández‐Pereira, et al. · Catheterization and Cardiovascular Interventions · 22

One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers Study

2019 · Alfredo E Rodriguez, Miguel Larribau, et al. · Clinical Medicine Insights Cardiology · 4

TCT-577 Revascularization Strategies for Patients with Multiple Vessel Coronary Disease and Unprotected left main. Mid term Results from a Prospective, Multicenter and Controlled Argentina Registry with a Cobalt- Chromium Rapamycin Eluting Stent, FIREBIRD 2® (ERACI 4)

2014 · Carlos Fernandez-Pereira, Ignacio Rifourcat, et al. · Journal of the American College of Cardiology · 1

Uso de drogas inhibidoras de P2Y12, clopidogrel, prasugrel y ticagrelor, en pacientes sometidos a intervenciones coronarias percutáneas en el mundo real en la Argentina. Resultados de los Registros ERACI IV y WALTZ

2019 · Sanatorio Otamendi, Argentina., A M Rodríguez-Granillo, et al. · Revista Argentina de Cardioangiología Intervencionista

In Hospital and 30 Days Results of the Prospective, Observational, Multicenter and Controlled “real world” WALTZ Registry

2017 · Juan Lloberas, Jorge Iravedra, et al. · Revista Argentina de Cardioangiología Intervencionista

CRT-200.30 Three Years Follow-up Of The Eraci IV Registry - A Modified Syntax Score For The Treatment Of Multiple Vessel Disease And Left Main Stenosis

2017 · Carlos Fernandez-Pereira, Juan Mieres, et al. · JACC: Cardiovascular Interventions

Works count: 6

Citation count: 27

H-index: 2

I10-index: 1